Evidence map›Paper›PMID 32295424›Full record

ReviewArteriosclerosis, thrombosis, and vascular biology2020

Megakaryocyte and Platelet Transcriptomics for Discoveries in Human Health and Disease.

Pavel Davizon-Castillo, Jesse W Rowley, Matthew T Rondina

Open access · hybridAbstract readComparative StudyReview
In one paragraph

Review in Arteriosclerosis, thrombosis, and vascular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 95 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Characterizing the effect of bariatric surgery on circulating S100A9.International journal of obesity (2005) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Pavel Davizon-CastilloFrom the Section of Pediatric Hematology, Oncology, and Bone Marrow Transplant, University of Colorado, Aurora (P.D.-C).
Jesse W RowleyUniversity of Utah Molecular Medicine Program, University of Utah, Salt Lake City (J.W.R., M.T.R.).
Matthew T RondinaFrom the Section of Pediatric Hematology, Oncology, and Bone Marrow Transplant, University of Colorado, Aurora (P.D.-C).
University of Colorado Anschutz Medical Campus · USUniversity of Utah · US

Funding

Pediatric Scientist Development Program (PSDP) [K12]K12HD000850 · NICHD · YALE UNIVERSITY · PI Sallie R. Permar · 1987 to 2026
$44.1M
Mitochondrial fusion protein MFN2 prevents platelet death and dysfunctionR01HL144957 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI JESSE ROWLEY · 2019 to 2026
$3.2M
Genomics of Megakaryocyte and Platelet BiologyR01HL139825 · NHLBI · WASHINGTON UNIVERSITY · PI DI PAOLA, JORGE A · 2020 to 2023
$2.3M
Translational Control of Megakaryocyte and Platelet Function in SepsisR01HL142804 · NHLBI · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2018 to 2021
$1.9M
Platelet Immune Responses in Aging and InfluenzaR01AG048022 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2014 to 2018
$1.8M
OPA1 an Estrogen-Mediated Modulator of Platelet HyperactivationR61HL141783 · NHLBI · UNIVERSITY OF IOWA · PI ABEL, E DALE, WEYRICH, ANDREW S · 2018 to 2019
$1.5M
Novel Regulatory Mechanisms of Inflammation-Induced ThrombosisR56AG059877 · NIA · UNIVERSITY OF UTAH · PI RONDINA, MATTHEW THOMAS · 2018 to 2018
$381k
Platelet Reprogramming During InflammationI01CX001696 · VA · VA SALT LAKE CITY HEALTHCARE SYSTEM · PI Matthew Thomas Rondina · 2018 to 2026
–
CSRD VA I01 CX001696NHLBI NIH HHS R01 HL139825NHLBI NIH HHS R01 HL142804NHLBI NIH HHS R01 HL144957NHLBI NIH HHS R61 HL141783NIA NIH HHS R01 AG048022NIA NIH HHS R56 AG059877NICHD NIH HHS K12 HD000850
6 · The paper itself

Abstract

Anucleate platelets, long viewed as merely cell fragments with a limited repertoire of rapid-acting hemostatic functions, are now recognized to have a complex and dynamic transcriptome mirroring that of many nucleated cells. The field of megakaryocyte and platelet transcriptomics has been rapidly growing, particularly with the advent of newer technologies such as next-generation RNA-sequencing. Studies interrogating the megakaryocyte and platelet transcriptome have led to a number of key insights into human health and disease. In this brief focused review, we will discuss some of the recent discoveries made through transcriptome analysis of megakaryocytes and platelets. We will also highlight the utility of integrating ribosome footprint analysis to augment discoveries. Both bulk and single-cell sequencing approaches will be reviewed, along with comparative studies between human and murine platelets under basal healthy settings and during acute systemic inflammatory diseases.

Indexed as

Blood PlateletsGene Expression ProfilingMegakaryocytesAdultAgedAgingAnimalsCross-Sectional StudiesHealth StatusHemostasisHigh-Throughput Nucleotide SequencingHIV InfectionsHumansLongitudinal StudiesMiceSequence Analysis, RNAgene expression profilinghemostasismegakaryocytesribosomestranscriptome

Identifiers

PMID32295424
PMCPMC7253186
OpenAlexW3017024756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.